Nom du produit:5-[(3-chloro-2-fluorophenyl)methyl]-3,3-difluoro-4-hydroxypyrrolidin-2-one
IUPAC Name:5-[(3-chloro-2-fluorophenyl)methyl]-3,3-difluoro-4-hydroxypyrrolidin-2-one
- CAS:2460728-19-0
- Formule moléculaire:C11H9ClF3NO2
- Pureté:95%+
- Numéro de catalogue:CM1075329
- Poids moléculaire:279.64
Unité d'emballage |
Stock disponible |
Prix($) |
Quantité |
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:2460728-19-0
- Formule moléculaire:C11H9ClF3NO2
- Point de fusion:-
- Code SMILES:O=C1NC(CC=2C=CC=C(Cl)C2F)C(O)C1(F)F
- Densité:
- Numéro de catalogue:CM1075329
- Poids moléculaire:279.64
- Point d'ébullition:
- N° Mdl:
- Stockage:
Category Infos
- Pyrrolidines
- Pyrrolidine, also known as tetrahydropyrrole, is a saturated five-membered heterocyclic ring, which is miscible with water. Pyrrolidine exists in many alkaloids and drug molecules, such as kappa opioids, antagonists of dopamine D4 receptors, and HIV reverse transcriptase inhibitors.
Column Infos
- TAK-861
- Takeda announced positive topline results from a randomized, double-blind, placebo-controlled, multiple dose Phase 2b trial evaluating TAK-861, an oral orexin receptor 2 (OX2R) agonist, in patients with narcolepsy type 1 and intends to rapidly initiate the first global Phase 3 trials of TAK-861 in first half of fiscal year 2024.